Alnylam Pharmaceuticals's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Alnylam Pharmaceuticals last closed at $224.53 (+0.05%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 38.4×. Its overall grade ranks 392 of 738 stocks in Healthcare.
About this company
Alnylam Pharmaceuticals last closed at $224.53 (+0.05%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 392/738
Valuation grade F
Related stocks
- SanofiCustomer
파트너십을 통한 혈우병/희귀질환 치료제 상업화 및 공동개발 관계
- Regeneron PharmaceuticalsCustomer
inclisiran 계열 및 희귀질환 파이프라인 관련 공동개발/상업화 협력 이력
- NovartisCustomer
RNAi 치료제 공동개발 및 라이선스 파트너 관계
ETFs holding this stock
T. Rowe Price Health Care ETF · iShares Biotechnology ETF · Invesco Nasdaq Biotechnology ETF
Details →About Alnylam Pharmaceuticals
- What technical signals does Alnylam Pharmaceuticals (ALNY) have?
- Alnylam Pharmaceuticals current technical signals: no active technical signal.
- Is Alnylam Pharmaceuticals a cup-and-handle pattern?
- No. Alnylam Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Alnylam Pharmaceuticals?
- Market cap: $29.66B. Trailing 12 months PER: 38.4×. Latest quarter PBR: 22.92×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Alnylam Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.